Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New therapeutic strategies based on biasing IL-2 mutants for cancers and autoimmune diseases

19 Jun 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 35732097
DOI: 10.1016/j.intimp.2022.108935

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New therapeutic strategies based on biasing IL-2 mutants for cancers and autoimmune diseasesPMID 35732097Read ↗

Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategiesSemantic proximity Read ↗

Dismantling the immune system.Semantic proximity Read ↗

Human IL-2 mutein with higher antitumor efficacy than wild type IL-2.Semantic proximity Read ↗

IL-2-driven CD8+ T cell phenotypes: implications for immunotherapy.Semantic proximity Read ↗

Targeting the TNF and TNFR superfamilies in autoimmune disease and cancerSemantic proximity Read ↗

Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer?Semantic proximity Read ↗

The science and medicine of human immunology.Semantic proximity Read ↗

Experiments of nature: primary immune defects deciphered and defeated.Semantic proximity Read ↗

A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo.Semantic proximity Read ↗

Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology.Semantic proximity Read ↗

Context-dependent effects of IL-2 rewire immunity into distinct cellular circuitsSemantic proximity Read ↗

Humanized mouse models of immunological diseases and precision medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.